Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis.
Saved in:
| Title: | Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis. |
|---|---|
| Authors: | Aragón*, Carlota Abbad-Jaime de1 (AUTHOR), Berna-Rico*, Emilio1 (AUTHOR), Goas, Almudena2 (AUTHOR), Pérez-Bootello, Javier1 (AUTHOR), Ballester-Martinez, María Asunción1 (AUTHOR), Jaén, Pedro1 (AUTHOR), Blauvelt, Andrew3 (AUTHOR), González-Cantero, Álvaro1,2 (AUTHOR) alvarogc261893@hotmail.com |
| Source: | Clinical & Experimental Dermatology. Mar2024, Vol. 49 Issue 3, p272-273. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 175672544 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Aragón*%2C+Carlota+Abbad-Jaime+de%22">Aragón*, Carlota Abbad-Jaime de</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berna-Rico*%2C+Emilio%22">Berna-Rico*, Emilio</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goas%2C+Almudena%22">Goas, Almudena</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pérez-Bootello%2C+Javier%22">Pérez-Bootello, Javier</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ballester-Martinez%2C+María+Asunción%22">Ballester-Martinez, María Asunción</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jaén%2C+Pedro%22">Jaén, Pedro</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blauvelt%2C+Andrew%22">Blauvelt, Andrew</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22González-Cantero%2C+Álvaro%22">González-Cantero, Álvaro</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> alvarogc261893@hotmail.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Experimental+Dermatology%22">Clinical & Experimental Dermatology</searchLink>. Mar2024, Vol. 49 Issue 3, p272-273. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175672544 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ced/llad361 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: 272 Titles: – TitleFull: Tildrakizumab-induction therapy followed by as-needed dosing in patients with mild-to-moderate psoriasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aragón*, Carlota Abbad-Jaime de – PersonEntity: Name: NameFull: Berna-Rico*, Emilio – PersonEntity: Name: NameFull: Goas, Almudena – PersonEntity: Name: NameFull: Pérez-Bootello, Javier – PersonEntity: Name: NameFull: Ballester-Martinez, María Asunción – PersonEntity: Name: NameFull: Jaén, Pedro – PersonEntity: Name: NameFull: Blauvelt, Andrew – PersonEntity: Name: NameFull: González-Cantero, Álvaro IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 03076938 Numbering: – Type: volume Value: 49 – Type: issue Value: 3 Titles: – TitleFull: Clinical & Experimental Dermatology Type: main |
| ResultId | 1 |
